SLXN - Silexion Therapeutics Corp
0.985
0.008 0.802%
Share volume: 527,932
Last Updated: 05-07-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$0.98
0.01
0.01%
View ratios
| Fiscal Date | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 08-29-2024 | 11-14-2024 | 03-18-2025 | |
| Total revenue | -102.000 K | -3.822 M | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | |
| Gross profit | -102.000 K | -3.822 M | 0.000 | |
| -3,647.06% | 100.00% | |||
| Operating expenses | 1.385 M | 8.036 M | 0.000 | |
| Selling general and admin | 619.000 K | 4.819 M | 0.000 | |
| Research and development | 766.000 K | 3.217 M | 0.000 | |
| Total expenses | 1.385 M | 8.036 M | 0.000 | |
| 480.22% | -100.00% | |||
| Operating income | -1.385 M | -8.036 M | 0.000 | |
| Ebit | -1.385 M | -8.036 M | 0.000 | |
| Pretax income | -1.487 M | -11.858 M | 0.000 | |
| 697.44% | -100.00% | |||
| Income tax | 2.000 K | 2.000 K | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -1.489 M | -11.860 M | 0.000 | |
| -696.51% | 100.00% |
